<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02086890</url>
  </required_header>
  <id_info>
    <org_study_id>01311402F</org_study_id>
    <secondary_id>R21EY023720</secondary_id>
    <nct_id>NCT02086890</nct_id>
  </id_info>
  <brief_title>Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa</brief_title>
  <official_title>Modulating Ocular/Retinal Blood Flow and Visual Function in Retinitis Pigmentosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nova Southeastern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Nova Southeastern University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Measures of vision in RP patients receiving promising therapy using transcorneal electrical&#xD;
      stimulation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retinitis pigmentosa (RP) is a slowly progressive retinal degeneration for which there is no&#xD;
      proven treatment. Patients are interested in trying alternative therapies to try to reduce&#xD;
      their vision loss, but only limited research evidence exists to support their use and&#xD;
      potential benefit. The goal of this research project is to gain a better understanding of&#xD;
      possible changes in ocular and retinal blood flow and measures of vision in RP patients&#xD;
      receiving two promising therapies, electroacupuncture and transcorneal electrical&#xD;
      stimulation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 2014</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Significant changes from baseline in Goldmann visual field area in both eyes</measure>
    <time_frame>twice at baseline, then 2 weeks, 6 weeks and 12 weeks post-intervention initiation</time_frame>
    <description>Using Haig-Streit Octopus perimeter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Significant changes from baseline in Dark adaptation function at both 2 weeks and 6 weeks post-intervention initiation</measure>
    <time_frame>twice at baseline, then 2 weeks, 6 weeks and 12 weeks post-intervention initiation</time_frame>
    <description>Using the AdaptDx by Maculogix</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Significant changes from baseline in best-corrected ETDRS visual acuity at both 2 weeks and 6 weeks post-intervention initiation</measure>
    <time_frame>twice at baseline, then 2 weeks, 6 weeks and 12 weeks post-intervention initiation</time_frame>
    <description>Using Pelli-Robson visual acuity charts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Significant changes from baseline in contrast sensitivity at both 2 weeks and 6 weeks post-intervention initiation</measure>
    <time_frame>twice at baseline, then 2 weeks, 6 weeks and 12 weeks post-intervention initiation</time_frame>
    <description>Using Adaptive Sensory Technology Quick CSF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Macular edema Optical Coherence Tomography (OCT)</measure>
    <time_frame>twice at baseline, then 2 weeks, 6 weeks and 12 weeks post-intervention initiation</time_frame>
    <description>Using Optical Coherence Tomography</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">21</enrollment>
  <condition>Retinitis Pigmentosa</condition>
  <arm_group>
    <arm_group_label>Electro-acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electro-acupuncture applied to acupoints around the eye and traditional needle acupuncture applied to acupoints throughout the body at 10 half-hour sessions over 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Electro-acupuncture</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>No electro-acupuncture applied to non-acupoints around the eye and traditional needle acupuncture applied to non-acupoints throughout the body; i.e., to locations not on the acupuncture meridians; at 10 half-hour sessions over 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laser acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laser applied to acupoints throughout the body at 10 sessions each lasting 15 minutes over a 2 week period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Laser acupuncture</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>An inactive sham laser (red light only) applied to non-acupoints throughout the body; i.e., to locations not on the acupuncture meridians; at 10 sessions each lasting 15 minutes over a 2 week period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transcorneal Electrical Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcorneal Electrical Stimulation at 150% individual phosphene threshold applied to both eyes using DTL electrodes at 6 weekly 30 minute sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Transcorneal Electrical Stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham Transcorneal Electrical Stimulation at 0% individual phosphene threshold (no stimulation) applied to both eyes using DTL electrodes at 6 weekly 30 minute sessions</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electro-acupuncture</intervention_name>
    <arm_group_label>Electro-acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser Acupuncture</intervention_name>
    <arm_group_label>Laser acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcorneal Electrical Stimulation</intervention_name>
    <arm_group_label>Transcorneal Electrical Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Electro-acupuncture</intervention_name>
    <arm_group_label>Sham Electro-acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham laser acupuncture</intervention_name>
    <arm_group_label>Sham Laser acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham transcorneal electrical stimulation</intervention_name>
    <arm_group_label>Sham Transcorneal Electrical Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18+&#xD;
&#xD;
          -  Diagnosis of retinitis pigmentosa (RP)&#xD;
&#xD;
          -  Best-corrected visual acuity better than 20/400 in at least one eye&#xD;
&#xD;
          -  More than 20% loss of Goldmann Visual Field area (III4e test target) in at least one&#xD;
             eye&#xD;
&#xD;
          -  Able and willing to participate in all study visits for a ~4-6 month period&#xD;
&#xD;
          -  Provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Very severe vision losses in both eyes (e.g., hand motions or light perception only)&#xD;
             with difficulty performing the proposed vision tests&#xD;
&#xD;
          -  Vision loss due to ocular diseases other than RP, cystoid macular edema, or cataracts&#xD;
&#xD;
          -  Schedules do not permit participation in all study visits&#xD;
&#xD;
          -  Previous acupuncture or TES treatment for RP&#xD;
&#xD;
          -  Inability to understand study procedures or communicate responses to visual stimuli in&#xD;
             a consistent manner (cognitive impairment)&#xD;
&#xD;
          -  Dementia; Long or short-term memory loss&#xD;
&#xD;
          -  Unable to read or speak English&#xD;
&#xD;
          -  Smoking, excessive alcohol, or illegal drug use&#xD;
&#xD;
          -  Receiving current psychiatric care (i.e. unstable emotional and mental health status)&#xD;
&#xD;
          -  History of excessive bleeding&#xD;
&#xD;
          -  Reduced general health and/or systemic medications that may diminish the potential&#xD;
             response to the electroacupuncture treatments&#xD;
&#xD;
          -  Implanted cardiac pacemaker&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth R Seger, OD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nova Southeastern University; College of Optometry</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33328</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bittner AK, Gould JM, Rosenfarb A, Rozanski C, Dagnelie G. A pilot study of an acupuncture protocol to improve visual function in retinitis pigmentosa patients. Clin Exp Optom. 2014 May;97(3):240-7. doi: 10.1111/cxo.12117. Epub 2013 Oct 29.</citation>
    <PMID>24773463</PMID>
  </reference>
  <results_reference>
    <citation>Bittner AK, Seger K. Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):299-306. doi: 10.1007/s00417-017-3858-8. Epub 2017 Dec 8.</citation>
    <PMID>29222719</PMID>
  </results_reference>
  <results_reference>
    <citation>Bittner AK, Seger K, Salveson R, Kayser S, Morrison N, Vargas P, Mendelsohn D, Han J, Bi H, Dagnelie G, Benavente A, Ramella-Roman J. Randomized controlled trial of electro-stimulation therapies to modulate retinal blood flow and visual function in retinitis pigmentosa. Acta Ophthalmol. 2018 May;96(3):e366-e376. doi: 10.1111/aos.13581. Epub 2017 Nov 11.</citation>
    <PMID>29130647</PMID>
  </results_reference>
  <results_reference>
    <citation>Kayser S, Vargas P, Mendelsohn D, Han J, Bi H, Benavente A, Bittner AK. Reduced Central Retinal Artery Blood Flow Is Related to Impaired Central Visual Function in Retinitis Pigmentosa Patients. Curr Eye Res. 2017 Nov;42(11):1503-1510. doi: 10.1080/02713683.2017.1338350. Epub 2017 Sep 14.</citation>
    <PMID>28910168</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 10, 2014</study_first_submitted>
  <study_first_submitted_qc>March 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2014</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nova Southeastern University</investigator_affiliation>
    <investigator_full_name>Kenneth Seger</investigator_full_name>
    <investigator_title>Associate Professor, HPD-College of Optometry</investigator_title>
  </responsible_party>
  <keyword>retinitis pigmentosa</keyword>
  <keyword>acupuncture</keyword>
  <keyword>electroacupuncture</keyword>
  <keyword>transcorneal electrical stimulation</keyword>
  <keyword>microcurrent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

